Cheryl Matter, PhD, discusses an AI decision support tool that can improve prostate cancer treatment. A half-dose of abiraterone acetate is potentially as safe and effective as the standard dose for mHSPC and mCRPC. Researchers mapped how prostate cancer transforms into its deadliest form, NEPC, revealing a new drug target. The IsoPSA biomarker displays superior diagnostic accuracy in the early detection of prostate cancer, thereby helping to ...